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ABSTRACT
Syphilis still remains a major health concern worldwide because of the possibility of serious medical and psychological 
consequences, long-term disability, and death. Neurosyphilis (NS) may occur at any stage of infection. Its clinical 
presentation has been changing over recent years including psychiatric and neurocognitive symptoms. Several recent 
studies have described cases with these symptoms as the principal signs of NS. We present the case of neurosyphilis with 
a psychiatric presentation characterized by mood disturbance and auditory and visual hallucinations. 
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CASE REPORT
A 48-year-old man was brought to the emergency 
care unit with a 2-week history of malaise and 
headache followed by abnormal behavior over the 
last week, when he presented a depressed mood and 
an alteration in his mental status with disorientation, 
uncooperativeness, and self-aggressiveness. Indeed, 
the patient attempted suicide by trying to hang himself. 
There was no history of any previous similar episodes, 
psychiatric diseases, fever, other signs of infection, 
head trauma, or abuse of illegal substances.
The patient was previously diagnosed with 
hypertension and diabetes mellitus, and was taking 
enalapril, metformin and glicazide. There were no 
reports of tobacco or alcohol consumption, nor any 
familial history of psychiatric diseases.
On the initial examination, the patient was ruddy, 
afebrile, and hydrated. His heart rate was 87 beats 
per minute; arterial pressure was 140/110 mmHg, 
respiratory rate was 14 breaths per minute; and 
capillary glycemia was 237 mg/dL.
The cardiovascular, pulmonary, abdominal, and 
skin examination was normal. The mental status on 
admission showed a Glasgow Coma Scale (GCS) 
of 10, and he was uncooperative, inattentive, and 
disorientated. His pupils were normal and no motor 
deficit was detected.
The initial laboratory work-up and the brain 
computerized tomography were normal. A cerebrospinal 
fluid (CSF) examination (lumbar puncture) was 
performed and the results are presented in Table 1. 
The diagnosis of encephalitis due to the herpes 
simplex virus (HSV) was suspected and intravenous 
acyclovir was promptly prescribed, as recommended 
by Studahl et al.1. Polymerase chain reaction for 
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HSV was not requested due to its unavailability. 
The electroencephalogram was normal.
After 7 days of anti-viral therapy (acyclovir, 
10 mg/kg, tree times daily), no clinical improvement 
was observed, and indeed a new CSF examination 
resulted in worsened cytological and biochemical 
parameters (Table 1). Therefore, serum fluorescent 
treponemal antibody and the Venereal Disease 
Research Laboratory (VDRL) were requested that 
resulted positive. The VDRL title was 1/128. The VDRL 
in the CSF also resulted in the same title (1/128). 
Table 2 shows the electrophorectic profile of the CSF 
proteins. Intravenous crystalline G penicillin at a dosage 
of 24 million units per day in six divided doses over 
14 days was prescribed and acyclovir was discontinued 
on the eighth day. The magnetic resonance imaging 
(MRI) of the brain revealed oval spots of hyperintensity 
on T2-weighted and fluid attenuated inversion recovery 
(FLAIR) sequences involving subcortical white matter 
of the superior frontal gyri.
Marked clinical improvement was observed after 
30 hours of antibiotic therapy. The patient achieved 
a GCS of 15 and started managing his basic daily 
living activities. However, he started complaining of 
visual and auditory hallucinations with persecutory 
content that were controlled after the administration 
of risperidone.
At the end of the penicillin therapy, the patient’s 
wife reported his normal behavior. He was discharged 
to continue medical monitoring in the outpatient clinic.
DISCUSSION
Syphilis is a major global health issue. Worldwide, 
36.4 million people were estimated to be infected with 
Treponema pallidum, and 10.6 million new cases of 
syphilis were reported in 2008.4 Neurosyphilis (NS) 
occurs in up to 30% of people with untreated syphilis 
and may occur at any stage of the infection.5 Although 
a decline in the incidence and prevalence of syphilis 
has been considered as its continuing trend, currently, 
an increase in new cases of the disease points to the 
contrary. Meanwhile, the clinical presentation of NS 
has been changing. Whereas 69% of cases were typical 
from 1965 to 1984, 86% of cases were atypical from 
1995 to 2005.6
Neu ro s yph i l i s  ha s  a  w ide  spec t rum o f 
neurocognitive symptoms that, apart from being 
non-specific, are also common to many neurologic and 
psychiatric disorders.5 Early invasion (not necessarily 
Table 1. Cerebrospinal fluid examination (lumber puncture)
Admission Day 7 RV2
Appearance Slightly turbid Slightly turbid Crystal clear
WBC count 181 303 < 6 WBC/mm3
Neutrophil 12 4 Occasional
Lymphocyte 81 87 70%
Monocyte 7 9 30%
RBC count 2 5 0
Total protein 91.1 119.8 18-58 mg/dL
Glucose 121 58 2/3 serum glucose
Lactate 30.1 31.3 < 35 mg/dL
Gram stain Negative NA Negative
Culture Negative NA Sterile
RBC = red blood cell; RV = reference value; WBC = white blood cell.
Table 2. Cerebrospinal fluid protein electrophoresis
RV3
Total protein 119.8 18-58 mg/dL
Pre albumin 2 3-7 mg/dL
Albumin 34.6 45-70 mg/dL
α-1 globulin 2 3-7 mg/dL
α-2 globulin 3.4 5-11 mg/dL
β-globulin 6 7-13 mg/dL
δ-globulin 5.3 4-10 mg/dL
γ-globulin 46.8 5-12 mg/dL
RV = reference value.
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“involvement”) of the central nervous system (CNS) is 
thought to occur in many (if not most) patients infected 
with syphilis.7 The incubation period can vary from less 
than 2 years up to 20 years.5
NS is divided into early and late disease, and 
its forms include asymptomatic (most common), 
meningeal, meningovascular, and parenchymal, which 
includes general paresis and tabes dorsalis.6 Early 
neurosyphilis may be asymptomatic or may present 
as meningitis or meningovasculitis.5 Parenchymal NS 
is the most common presentation among symptomatic 
cases, presenting with clinical psychiatric picture, 
including dementia, depression, rage, psychosis, and 
cognitive impairment.6,8 Late neurosyphilis tends to 
affect the brain and spinal cord, typically presenting 
as tabes dorsalis, general paresis, sensory ataxia, 
or bowel/bladder dysfunction.8 The frequency of 
psychiatric signs and symptoms associated with NS 
reported in literature ranges from 33% to 86%.9,10 
The most common presenting neuropsychological 
symptoms compr ise personal i ty  change and 
hallucinations (in 48% of patients).8
Lin et al.11 conducted a study on NS showing 
that 52 of the 169 patients presented psychiatric 
manifestations, and many of those patients had 
characteristics of more than one syndrome, including 
cognitive impairment, personality disorders, delirium, 
hostility, dysarthria, confusion, disruption of their 
sleep–wake cycle, fecal and urinary incontinence, 
dysphoria, paranoia, hallucinations, expansive mood, 
and mania. These results indicate that NS mimics almost 
all psychiatric disorders. Costiniuk and MacPherson5 
reported three cases of NS where the treatment was 
delayed because of the non-specific neurocognitive 
presentation. The patients presented hyperactivity, 
sleep disturbances, delusions of grandiosity, seizures, 
cognitive function impairment, memory alteration, 
lower-limb weakness and numbness, dysarthria with 
stuttering speech, and an inability to perform routine 
activities.
The Centers for Disease Control and Prevention 
(CDC) has established definition criteria to diagnose 
neurosyphilis. Two diagnostic categories are described: 
(i) “confirmed” neurosyphilis, which is defined as 
present in any stage of syphilis and a reactive CSF 
VDRL test; and (ii) “presumptive” neurosyphilis, 
which is defined as present in any stage of syphilis 
in the presence of a non-reactive CSF VDRL test, CSF 
pleocytosis, or elevated protein, and with clinical 
signs or symptoms consistent with syphilis without an 
alternate diagnosis to account for these.8 According 
to these criteria, our patient had a confirmed NS since 
he presented symptoms consistent with neurological 
involvement, and the serologic and the CSF test for 
VDRL was positive at 1/128.
The CSF is a sensitive indicator of the active 
neurosyphilitic infection. The CSF abnormalities consist 
of (i) pleocytosis of up to 100 cells/mm3, sometimes 
higher, which are mostly represented by lymphocytes 
and a few plasma cells and other mononuclear cells 
(the counts may be lower in patients with AIDS and 
those with leukopenia); (ii) elevation of the total 
protein from 40 mg/dL to 200 mg/dL; (iii) an increase 
in immunoglobulin G (IgG), usually with oligoclonal 
banding; and (iv) positive serologic tests. The CSF 
glucose content is usually normal. The earliest NS 
change in the CSF consists of pleocytosis and an 
elevation of protein, which may occur in the first few 
weeks of the infection before the positivity of the 
serologic tests. Later on, the CSF changes vary from a 
spontaneous or therapeutic remission of the disease 
when the cellularity returns to a normal count followed 
by the normalization of total protein, and afterwards 
the IgG concentration reduces. The positive serologic 
tests are the last to revert to normal.12
The CSF abnormalities in patients with serologic 
evidence for syphilis may occasionally be related to 
an altered blood-CSF barrier instead of intrathecal 
immunoglobulin (Ig) production. The Levchik et al.13 
study showed that reactive CSF-VDRL, elevated 
CSF-white blood cell count, and elevated CSF-T. pallidum 
hemagglutination (TPHA) titers/indices were associated 
with intrathecal Ig synthesis; whereas non-reactive 
CSF-fluorescent treponemal antibody absorption, 
non-reactive CSF-TPHA tests, and CSF-TPHA titers 
from 1:4 to 1:160 were associated with cases where 
the intrathecal synthesis was not detected. A classic 
study from Vartdal et al.14 has shown that elevated 
IgG in the CSF is produced intrathecally and has been 
shown to be adsorbed by T. pallidum, usually IgG with 
oligoclonal banding.
The imaging exams are usually useful for 
parenchymal evaluation in neurosyphilis, more 
specifically the MRI. In the study by Zheng et al.,15 
the MRI demonstrated brain atrophy in 87% of cases 
with psychiatric symptoms, primarily in the frontal 
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and temporal lobes. However, imaging should be 
interpreted with caution as normal MRI are also 
commonly found in those cases.5
Historically, the spirochetal infection of the CNS 
was a great public health concern because of the lack 
of any specific treatment. Several forms of treatment 
were proposed, including malariotherapy, which was 
developed in 1917 by Wagner-Jauregg (Nobel Prize 
winner in 1927), using a seizure triggered by malaria 
fever, and other seizure-inducing therapies (e.g. 
insulin therapy, electroconvulsive therapy) with poor 
outcomes.16 Nowadays, syphilis is an easy-to-treat 
and preventable illness. The treatment of all forms of 
neurosyphilis consists of the administration of penicillin 
G, given intravenously in a dosage of 18-24 million 
units daily (3-4 million units every 4 hours) for 
10-14 days. The CDC recommends procaine penicillin, 
or probenecid and ceftriaxone as an alternative for 
patients allergic to penicillin. The Jarisch–Herxheimer 
reaction, which occurs after the first dose of penicillin 
and is a matter of concern in the treatment of primary 
syphilis, is of little concern in neurosyphilis; it usually 
consists of nothing more than a mild temperature 
elevation and leukocytosis.12
The NS follow-up after treatment consists of 
a neurologic examination and lumbar puncture 
3-6 months after treatment and every 6 months 
thereafter until the CSF white blood cell count 
achieves the normal limits and the CSF-VDRL becomes 
non-reactive. The CSF white blood cell count should 
decline at 6 months after successful treatment, and all 
CSF abnormalities should resolve within 2 years after 
treatment. Failure to meet these criteria indicates the 
necessity of retreatment. Retreatment is also indicated 
if any follow-up CSF sample shows an increase in the 
CSF white blood cell count or a four-fold increase in 
CSF-VDRL titer.12,17
CONCLUSION
This case illustrates the challenge in diagnosing 
neurosyphilis and the need to consider serologic testing 
for syphilis in patients with atypical presentation 
of depression with neurocognitive abnormalities, 
autoaggressiveness, late onset of mental disorder 
with acute behavioral symptoms, and lack of history 
of previous mental illness.
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